About Viva Biotech - About Us

About
Viva Biotech

Established in 2008, Viva Biotech Holdings (01873.HK) provides one-stop services ranging from early-stage Structure-Based Drug R&D to commercial manufacturing to global biopharmaceutical innovators. Leveraging our leading edge in AI-driven structure-based drug discovery (SBDD), the Company provides CRO services covering the drug discovery stage to global partners. Through the synergistic development of its biology and chemistry capabilities, the Company has established an integrated R&D platform spanning multiple drug modalities, including small molecules, large molecules/antibodies, peptides, PROTACs/molecular glues, and XDCs. With our subsidiary, Langhua Pharma, we offer our worldwide pharmaceutical and biotech partners a one-stop integrated CMC/CDMO solution from preclinical to commercial manufacturing. Additionally, we embedded an equity for service (EFS) model to high potential startups to address unmet medical needs.

2,904

Biotech and pharmaceutical clients worldwide
2,213

Employees worldwide
67

Domestic and foreign patents
93

Invested and incubated companies

Learn more

Corporate
Culture

Learn more

Vision

To become a long-term partner of global innovative biotech companies.
Mission

Our mission is to fight diseases with research and services of drug discovery and development of cutting edge therapies, to improve life quality.
Our Values

Innovation

Innovation

With the leading advantages in the field of Structure-Based Drug R&D technology, we actively build an innovative technology platform, continue to expand and optimize services, and help the global R&D and production of innovative drugs.

Integrity and Professionalism

Integrity and Professionalism

Be honest and compliant, keep our promises, abide by professional ethics, and realize the improvement of self-worth and working ability.

Customer Success

Customer Success

Fully meet customer needs, create maximum values for customers, and continue to focus on customer satisfaction.

Win-win Cooperation

Win-win Cooperation

Achieve efficient internal and external coordination for a common goal, establish long-term cooperative relations with customers, and keep an open and win-win attitude to achieve common development.

cro

Drug R&D Services

With its leading position in Structure-Based Drug Discovery (SBDD), Viva provides state-of-the-art drug research and development services to global biotechnology and pharmaceutical customers for their preclinical, innovative drug discovery programs. We cover the all-around needs of our clients for their early drug research and development, including protein expression, purification and structure determination, hits screening, therapeutic antibody discovery, antibody expression and production, Bioassay, computer-aided drug design, medicinal chemistry and custom synthesis, ADME, and PK studies.

Learn more

cdmo

R&D and Production Services

As the subsidiary of Viva Biotech holdings, Langhua offers our worldwide partners One-Stop CDMO solution in new drug full life-cycle for small molecule Active Pharmaceutical Ingredients (APIs) and Finished Dosage Form, from pre-clinical to commercial supply.

Learn more

One-stop services ranging from early-stage Structure-Based Drug R&D to commercial drug delivery

Top Search: Expression and Purification of Recombinant Protein Hit Discovery APIs Synthesis Services Drug Product CDMO Services

Resources

One-Stop CRO&CDMO
Services Overview
Download